Analysts Are Bullish on Top Healthcare Stocks: Hinge Health, Inc. Class A (HNGE), Centene (CNC)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Hinge Health, Inc. Class A (HNGE – Research Report) and Centene (CNC – Research Report) with bullish sentiments.
Valentine's Day Sale - 70% Off
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Hinge Health, Inc. Class A (HNGE)
In a report released today, Saket Kalia from Barclays maintained a Buy rating on Hinge Health, Inc. Class A, with a price target of $60.00. The company’s shares closed last Friday at $31.17, close to its 52-week low of $30.88.
According to TipRanks.com, Kalia is a 4-star analyst with an average return of
Currently, the analyst consensus on Hinge Health, Inc. Class A is a Strong Buy with an average price target of $63.36, implying a 95.5% upside from current levels. In a report issued on January 25, TipRanks – PerPlexity also upgraded the stock to Buy with a $49.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
Centene (CNC)
Barclays analyst Andrew Mok CFA maintained a Buy rating on Centene today and set a price target of $54.00. The company’s shares closed last Friday at $38.46.
According to TipRanks.com, CFA is a 1-star analyst with an average return of
The word on The Street in general, suggests a Hold analyst consensus rating for Centene with a $43.75 average price target, which is a 17.5% upside from current levels. In a report issued on January 27, Bernstein also maintained a Buy rating on the stock with a $59.00 price target.
